Navigation Links
Watson Second Quarter 2011 Net Revenue Exceeds $1 Billion; Non-GAAP EPS of $1.01
Date:7/26/2011

27.6)(33.9)(49.0)(54.2)Non-GAAP net income attributable to
 common shareholders

$
27.9$
2.8$
239.8$
203.1Diluted earnings per share Diluted earnings per share - GAAP

$
.42$
.57$
.78$
.14Diluted earnings per share - Non-GAAP

$
.01$
.83$
.90$
.64Basic weighted average common shares outstanding

124.5122.3124.1122.0Effect of dilutive securities:   Dilutive share-based compensation arrangements

1.91.72.01.7Diluted weighted average common shares outstanding

126.4124.0126.1123.7(1)  Includes accelerated depreciation charges.   The following table presents a reconciliation of reported net income to adjusted EBITDA for the three and six months ended June 30, 2011 and 2010:

Table 5Watson Pharmaceuticals, Inc.Adjusted EBITDA Reconciliation Table(Unaudited; in millions)Three Months EndedJune 30,Six Months EndedJune 30,2011201020112010GAAP net income attributable to common shareholders$
52.7$
70.6$
98.0$
40.4Plus:Interest expense22.920.044.740.3Interest income(0.5)(0.3)(1.3)(0.7)Provision for income taxes43.227.984.564.6Depreciation (includes accelerated depreciation)25.726.648.751.3Amortization74.943.1132.082.1EBITDA218.9187.9406.6378.0Adjusted for:Global supply chain initiative2.012.78.516.5Acquisition and licensing charges8.72.113.321.5Non-cash impairment charges7.40.121.81.1Other (gains) losses(1.5)(1.4)(7.2)(24.8)Legal settlements---3.0Share-based compensation7.86.016.211.0Adjusted EBITDA$
243.3$
207.4$
459.2$
406.3The following table presents a reconciliation of forecasted net income for the twelve months ending December 31, 2011 to non-GAAP net income and non-GAAP earnings per diluted share:

Table 6Watson Pharmaceuticals, Inc.Reconciliation Table (Unaudited; in millions except per share amounts)Forecast for Twelve MonthsEnding December 31, 2011LowHighGAAP to non-GAAP net income calculationGAAP net income

$
226$
25
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Watson Confirms JALYN™ Patent Challenge
2. Watson Confirms Favorable Appeals Court Decision in Mucinex(R) Patent Suit
3. Watson Confirms Vyvanse® Patent Challenge
4. Watson to Host Conference Call and Webcast to Discuss Second Quarter 2011 Earnings
5. Watson Announces Expansion of Salt Lake City, Utah Pharmaceutical R&D and Manufacturing Facility
6. Watson to Present at 2011 Wells Fargo Securities Healthcare Conference
7. Watson Confirms AVODART(R) Patent Challenge
8. Watson Confirms Court Decision Rejecting Tevas Motion to Prevent Launch of Generic SEASONIQUE®
9. Watsons Nabumetone Tablets Receive FDA Approval
10. Watson Confirms Pataday™ Patent Challenge
11. Watson Confirms Viagra® Patent Challenge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... , July 13, 2014  Eli Lilly ... announced results from its non-clinical study in genetically ... version of the beta-amyloid antibody N3pG and beta-secretase ... therapy was more effective in removing clumps of ... that is thought to lead to Alzheimer,s disease ...
(Date:7/11/2014)... , July 11, 2014  Rock Creek Pharmaceuticals, Inc. ... today announced that the Food and Drug Administration ("FDA"), ... comments on RCP,s Investigational New Drug ("IND") application before ... in the US. Dr. Chris Chapman ... and comments on our IND. When we receive the ...
(Date:7/11/2014)... -- Kindred Hospital Houston Northwest, with Wound Care Specialists, ... new outpatient wound healing center.  The wound healing ... hard to heal wounds. Chronic wounds include diabetic ... leg wounds related to blood flow issues, post-surgical ... wounds which are complex and demonstrate delayed healing. ...
Breaking Medicine Technology:New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2
... April 16 Trubion Pharmaceuticals, Inc. (Nasdaq: ... present data regarding its SCORPION(TM) multispecific therapeutic technology ... Association of Cancer Research (AACR) in Denver, April ... present data demonstrating the selectivity and high potency ...
... April 16 Simbionix, the world,s leading,developer of medical ... LLC for distribution of Simbionix,s simulators and related,products. , ... in Russia, Ukraine and CIS countries and,is one of ... Johnson & Johnson LLC will have exclusive ...
Cached Medicine Technology:Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 2Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 3Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries 2
(Date:7/13/2014)... research in Nature Genetics identifies a ... that causes eosinophillic esophagitis (EoE), opening up potential ... food allergy. , EoE is a chronic ... triggered by allergic hypersensitivity to certain foods and ... cells called eosinophils (part of the body,s immune ...
(Date:7/13/2014)... Chromatography system is a physical method of separation ... samples such as air and water. Chromatography systems ... namely mobile phase and stationary phase. The components ... phase, followed by the differential rate of migration ... mixture. Chromatography system plays an important role in ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Victorian Hotel ... by promoting the rental of bikes for its "Cycle ... downtown Victorian Hotel to tour the area using a ... tax. Bicycle enthusiasts love to call Vancouver home, as ... for cycle travel and picturesque journeys through the countryside. ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Micro irrigation ... ensure proper water dispersal as wells as to maintain ... agriculture is projected to become a dominant revenue generator ... sophisticated methods to reduce resource costs has led to ... and plantations, and has further caused massive demand for ...
(Date:7/13/2014)... 13, 2014 Advanced boilers are ... least amount of fossil fuels, produce high-capacity power, ... to increased global warming and climate change concerns, ... reduce harmful gas emissions and pollutants coming from ... in the global advance boilers market., The global ...
Breaking Medicine News(10 mins):Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 2Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 3Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 2Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 3Health News:Victorian Hotel Creates Excitement by Adding "Cycle the City" Bike Rentals for Its Vancouver Hotel Rooms 2Health News:Agricultural Micro Irrigation System Market is Expected to Grow at a CAGR of 18.1%, from 2013 to 2018 - New Report by MicroMarket Monitor 2Health News:Agricultural Micro Irrigation System Market is Expected to Grow at a CAGR of 18.1%, from 2013 to 2018 - New Report by MicroMarket Monitor 3Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 2Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 3
... MATEO, Calif., Feb. 28 NeurogesX, Inc.,(Nasdaq: ... and,commercializing novel pain management therapies, announced today that,Anthony ... to a,panel focused on pain management at Susquehanna ... Conference. Mr. DiTonno,is scheduled to present on Tuesday, ...
... latest technologies and ... medical advancements, AUSTIN, Texas, ... hospital, officially opened the expansion of its,heart hospital today with the ... rated as the number one overall,cardiac program in the State of ...
... diagnose severity of bipolar illness , , THURSDAY, Feb. 28 ... mood disorders have been identified by Indiana University School ... the way bipolar illness is diagnosed and treated. , ... found varying levels of the biomarkers in participants with ...
... (TSX: MDS; NYSE:,MDZ), a leading provider of products ... that the Company will report first quarter,results for ... will also host an analyst conference call with ... Douglas Prince,Executive Vice-President Finance and Chief Financial Officer, ...
... to $977.3mm for Full Year; Up 27% to $268.0mm for ... Fourth Quarter, - Adjusted EPS (incl. Stock Compensation) Up ... for Fourth Quarter (GAAP EPS ... up 62% to $0.47), - Continuing New Win Momentum and Pipeline Strengthening Across Segments, - ...
... 28 Cardiva Medical, Inc., a,privately held medical ... announces that it will present the highlights of ... 9:20am at the Medtech,Insight/Windhover Information,s "Investment In Innovation ... at The,Venetian in Las Vegas, NV., The ...
Cached Medicine News:Health News:NeurogesX to Present at Susquehanna Financial Group's 2nd Annual SIGnificant Options in Healthcare Conference 2Health News:NeurogesX to Present at Susquehanna Financial Group's 2nd Annual SIGnificant Options in Healthcare Conference 3Health News:Heart Hospital of Austin's Expansion Increases Patient Capacity by 30 Percent 2Health News:Heart Hospital of Austin's Expansion Increases Patient Capacity by 30 Percent 3Health News:Heart Hospital of Austin's Expansion Increases Patient Capacity by 30 Percent 4Health News:Biomarkers for Mood May Alter Psychiatric Treatments 2Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 2Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 3Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 4Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 5Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 6Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 7Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 8Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 9Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 10Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 11Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 12Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 13Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 14Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 15Health News:Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the 'Investment in Innovation (In3) West' Conference on February 29, 2008 in Las Vegas, NV 2
DAVINCI® performs all required steps primary tube sampling, reagent dispensing, microplate incubation, washing and optical reading....
Inquire...
... IGFBP-3 contains 266 amino acids and is variably ... weight estimates of between 43 and 56 kDa. ... IGF-II with high affinity but do not bind ... structurally characterized at this time, IGFBP-3 has been ...
... handle up to 180'000 tests per year ... plates and is capable of processing up ... All assay steps, from loading of the ... controlled by Windows™-based software. Between 119 (standard ...
Medicine Products: